In vitro synergistic activity of colistin with aminoglycosides, beta-lactams and rifampin against multidrug-resistant gram-negative bacteria

Journal of Chemotherapy

Volumn 19, Issue 2, 2007, Pages 226-229

  Chitnis, S ^a   Chitnis, V ^b   Chitnis, D S ^a  

^a CHOITHRAM HOSPITAL AND RESEARCH CENTRE   (India)

^b SRI AUROBINDO INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFTAZIDIME; COLISTIN; GENTAMICIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; SULPERAZON;

ARTICLE; BACTERIUM ISOLATE; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HUMAN; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PSEUDOMONAS AERUGINOSA; URINALYSIS;

EID: 34247887427     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2007.19.2.226     Document Type: Article

References (11)

1. Linden P, Kusne S, Coley K, Fontes Paulo, Kramer D, Paterson D. Use of parenteral Colistin for the treatment of serious infection due to antimicrobial resistant Pseudomonas aeruginosa. Clin Infect Dis. 2003; 37: e154-e160.
2. Markou N, Apostolakos H, Koumovelious C, Athanasiou M, Koutsoukou A, Alamanso I, Gregorakos L. Intravenous Colistin in the treatment of sepsis from multiresistant gram-negative bacilli in critically ill patients. Crit Care 2003; 7(5): R78-R83.
3. Rynn C, Wooitan M, Bowker KE, Alan Hola H, Reeves DS. In vitro assessment of Colistin antipseudomanl antimicrobial interactions with other antibiotics. Clin Microbiol Infect 1999; 5 (1): 32-36.
4. Gunderson BW, Khalid Ibrahim, Hovde L, Timothy LF, Reed M, Rotschafer JC. Synergistic activity of Colistin and ceftazidime against multiantibiotic resistant Pseudomonas aeruginosa in an in vitro pharmacodynamic model. Antimicrob Agents Chemother 2003; 905-909.
5. Giamarellos-Bourboulis EJ, Sambutakou H, Galani I, Giamarellous H. In vitro interaction of Colistin and rifampin on multidrug resistant Pseudomonas aeruginosa. J Chemother 2003; 15 (3): 235-8.
6. Lorian V. Antibiotics in laboratory medicine. Barry AL ed. Procedure and theoretical consideration for testing antimicrobial agents in agar media. III edition. Baltimore: William and Wilkins, 1991: 1-16.
7. Lorian V. Antibiotics in laboratory medicine. In: Krogstad DJ, Moellering RC. eds. Combination of antibiotics, mechanism of interaction against bacteria. New York 1980; 305-306.
8. th informational supplement. NCCLS document M100-S12. Wayne, PA: NCCLS, 2002
9. Gales A, Reis A, Jones R. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and Colistin: review of available interpretative criteria and quality control guidelines. J Clin Microbiol 2001; 39: (1) 83-190.
10. Levin AS, Barone AA, Penco J, et al. Intravenous Colistin as therapy for nosocomial infection caused by multidrug resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 1999; 28: 1008.
11. Falagas ME, Bliziotis IA, Kasiakou SK, Panayiota A, Michalopoulos A. Outcome of infections due to pandrug-resistant (PDR) gram negative bacteria. BMC Infect Dis 2005; 5:24.